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Patient activation is a demonstration of people participating effectively in their own 




We developed a structured information booklet to promote patient activation and 
report the 1 year outcomes of a randomised controlled trial assessing its impact on 
diabetes care processes and on glycaemic control. 
 
Design and Setting:  
It is an open label cluster randomised trial involving all people with diabetes aged 
more than 18 years within Wolverhampton Clinical Commissioning Group.   
 
Methods: 
All people with diabetes were cluster randomised into a group who were multiply 
mailed (MM) at 0, 3 and 6 months whilst a control group were mailed once at 3 
months. Comparison of a Failed Process Score (FPS) between active and control 
groups was performed at the 0, 3 and 12 months and of HbA1c at baseline and 12 
months. 
 
Results and Conclusion:  
FPS improved significantly with multiple mailing (p=0.013), with particular impact on 
those with poor baseline FPS (≥2) (achieved FPS ≤1 at 12 months 49.2% vs. 46.0%, 
χ2=6.09, p<0.05).  
 
Overall HbA1c% across the year (adjusted) was significantly better with MM 
(p=0.021), with specific impact in those with a baseline HbA1c ≤7.5 (MM HbA1c% 




The direct provision of structured information to the people with diabetes activates 






Diabetes is a costly world-wide epidemic that requires further exploration of the 
concepts of patient engagement, enablement and empowerment and partnership 
working to activate people to self-care (1), and thus contribute to the amelioration of 
the many personal and societal aspects of the diseases’ burden (2, 3). Patient 
activation is a broad behavioural concept (4), and its intent is to encourage people 
with long term conditions such as diabetes to acquire the knowledge, skills and 
confidence to participate actively but also effectively in their own disease 
management as measurable in defined outcomes. A number of user focused non 
pharmacological interventions have demonstrated an effect on diabetes specific 
surrogate markers (5) and there is evidence that increased patient activation is 
associated with better behaviours and outcomes (6).   As such, it perhaps should be 
considered as an outcome of diabetes care provision in its own right (7). 
  
One traditional mechanism is to promote knowledge acquisition through structured 
education programs but they are costly, with uncertain outcomes and they have very 
poor uptake in the United Kingdom (8, 9). Another technique is the provision of 
structured and easy to understand information directly to users in an attempt to 
instigate action though self-directed reflective learning (10) which more recently has 
been encapsulated in the “Information prescription” initiative (11). It is not our 
intention in this paper to suggest one mechanism is better than the other, nor have 
we compared these 2 methodologies and both aspire to modify behaviour.  Our 
focus is on the use of information. 
 
In our local model of diabetes care, WICKED (Wolverhampton Interface Care, 
Knowledge Empowered Diabetes) , we have determined that it should be user 
centric, that patient activation is a service objective,  that patients have  a right to 
their own specific information, that patients should have the opportunity to use  that 
information to improve their care and to liaise in equal and informed partnership with 
those  providers of care by establishing their  agreed care plans in a recognised 
processes of care planning (12).   We also understand, as will any larger scale 
provider, that in our local health economy of around 265,000 people, with more than 
17,000 people with known diabetes and a high incidence rate of new diabetes, we 
must deliver any mechanism systematically and equitably, without exclusion or 
exception, and cheaply so as not embarrass resource requirements, and effectively 
so that it must be evidenced to be of benefit.   Yet there is no known trial to evaluate 
the impact of provision of individualised diabetes specific information to people with 
diabetes, agnostic of their attitudes, aptitudes or degree of engagement with the 
health service, on any measure of patient engagement. 
    
Having published preliminary outcomes (13) we are now presenting the end study 
full year findings of this large RCT to determine the impact of the universal provision 
of diabetes specific information on patient activation as measured by the rate of 
completion of key care processes in diabetes and, in addition, on the key diabetes 




As previously described (13), a systematically designed, structured and 
individualised report containing their core key diabetes related information, which 
was the intervention called “My Diabetes, My Information, My Plan” (available at 
www.wdconline.org.uk, attached as appendix 1), was mail delivered across our 
entire health economy to people with diabetes divided into 2 groups according to a 
cluster randomisation protocol (13). 
 
The recording or measurement of 9 key diabetes process measures and their 
outcomes were  analysed (HbA1c, systolic  blood pressure, cholesterol or 
cholesterol / HDL cholesterol ratio,  body mass index, recording of smoking status, 
retinal screening, urinary albumin creatinine ratio, serum creatinine, foot 
examination). For process outcomes, a reading within 15 months was taken as 
positive. The Failed Process Score (FPS) was zero if all measures were attained 
within 15 months and 9 meant all failed to be measured.  
 
The positive 3 month impact of a single mailing versus no mailing on diabetes 
process measure outcomes, measured as the Failed Process FPS, which taken as a 
marker of patient activation,  has already been published (13).    
  
At the end of 3 months, all people in the control group were crossed over also to 
receive the information booklet for the first time and for once only (single mailed, 
SM). People in the active group received the booklet a second time at 3 months and 
then finally a third time at 6 months (multiply mailed, MM). 
 
Both groups were followed up for 12 months from baseline. We continued to accrue 
data on a rolling monthly basis ensuring systematic quality in data capture as is our 
routine service practice (14) but it was not analysed until the end of 12 months 
period.  Therefore, the final analysis is a comparison of multiple mailings (n=3) 
delivered at baseline, 3 and 6 months  versus a single mailing undertaken at 3 
months. Compared to the baseline population, at the end of 12 months, 866 people 
in total were lost to ascertainment (deceased=453, moved away=378 and not 
traceable=35) leaving a final cohort of 13,956 people at the end of 12 months of the 
trial period.  
 
A complete log of all failed deliveries returned back to the department and all enquiry 
phone calls received was kept but this was not subject to any form of analysis as it 
was less than 1% and unlikely to be of any meaningful significance. 
  
Results are presented as the mean ± the standard deviation (SD) unless otherwise 
stated.  
 
All data were analysed on SPSS version 22 with the results of statistical tests taken 
as significant at p<0.05. Comparison of means was by Student’s t test or by the Man 
Whitney U tests for parametric and non-parametric data respectively, differences 
between proportions by the Chi square test and the analysis of the effects of 
confounding factors was by univariate or binary logistic regression analysis for 
ordinal or categorical data respectively.  
 
The study was registered in the UK national research database (UK CRN ref: DRN 
795, available at http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=14324) 
and US clinical trials database (Clinical Trials Registration: NCT02200965). Ethical 
permission was obtained from NHS Health Research Authority (NRES committee 
North East-York, REC Ref: 13/NE/0052) and further clarification was obtained from 




Demographic and clinical data are presented in Table 1, noting the minor differences 
between groups for deprivation score, BMI, systolic blood pressure and CHD risk 
status. 
 
The Failed Process Score 
 
The mean baseline FPS was not significantly different between groups (Table 2) 
whilst mean FPS was significantly lower at 12 months in those multiply mailed (p = 
0.013).  For those with a baseline FPS <=1, neither the baseline FPs score nor the 
12 months FPS score was different between groups and nor was there any 
significant difference in the proportion that deteriorated to FPS >=2 (MM 28% vs. SM 
28%, ns). However, for those with a baseline FPS >=2, the mean baseline FPS was 
similar, but, at 12 months, FPS was significantly better in those multiply mailed 
(p=0.002) and significantly more attained a good FPS category of <=1 (MM 49% vs. 
SM 46%; χ2 = 6.09, p = 0.014). In those with baseline FPS >=2, in binary logistic 
regression (χ2 = 370.9, p<0.001), significant factors for attaining 12 months FPS ≤1 
were baseline FPS (p<0.001), gender (p=0.022) and multiple mailing (p=0.028) such 
that the likelihood ratio of achieving the good attainment category of FPS ≤1 with 




We selected those who had both a baseline HbA1c measure and a repeat HbA1c at 
least 6 months after the initial mailing date (n= 10015, MM 5637, single SM 4378). 
Their baseline characteristics showed no significant difference for age, gender, 
ethnicity, type of diabetes, duration of diabetes, baseline FPS score or baseline % 
glycated HbA1c (MM 7.8 ± 1.64 vs. 7.8 ± 1.62) but small but significant differences 
were found for the index of deprivation (MM 34.7 ± 15.8 vs. 35.9  ± 16.5, p = 0.001) 
and BMI (MM 30.8 ± 6.1 vs. SM 31.2 ± 6.2 kg/m2, p = 0.013). In the whole cohort 
HbA1c improved over the year (baseline HbA1c% 7.8 ± 1.6 vs. final HbA1c 7.5 ± 1.6, 
p<0.001) (Fig 1, top panel).  The crude end year HbA1c was not significantly 
different between groups (MM 7.5 ± 1.6 vs. SM 7.6 ± 1.6, ns). However, adjusting for 
relevant factors (univariate regression analysis, F=54.4, r2 = 0.12, p<0.001: age 
(p<0.001); duration of diabetes (p<0.001), BMI (p<0.001) but gender, ethnicity and 
type of diabetes all non-significant), then the MM group differed significantly from 
those singly mailed (F = 5.32, p = 0.021) with an adjusted mean (± SEM) difference 
of minus 0.2 ± 0.08 HbA1c%. Introducing baseline HbA1c% categories as ≤7.5, 7.6-
8.4 and ≥8.5 into the model (F=99.9, r2=0.40, p<0.001: age, p<0.001; duration of 
diabetes, p<0.001; gender, ethnicity, IMD score, BMI and type of diabetes all not 
significant), showed the impact of being multiply mailed remained significant (F = 
3.97, p=0.046) but with a strong effect according to baseline HbA1c category 
(F=363.9, p<0.001).  The significant point difference lay amongst those in the 
baseline HbA1c category ≤7.5 (MM HbA1c% 6.7 ± 0.07 (mean ± SEM) versus 7.0 ± 
0.09, mean difference (± SEM) of 0.3 ± 0.1, F=11.1, p=0.009).  Analysis of the 
change between final and initial HbA1c values by HbA1c category (Fig 1, bottom 
panel) showed this to be an improvement or at least avoidance of deterioration of 
HbA1c levels in those multi mailed in the HbA1c% category ≤7.5, amongst whom the 







The positive outcomes for the impact of a patient activation tool, “My Diabetes, My 
Information, My Plan”, on diabetes process attainment (FPS) and glycaemic control 
(HbA1c) are novel.  
 
They should be considered in relationship to the potential to benefit as well as the 
balance of the likely impact of patient activation versus the magnitude of service 
inactivation. 
 
For the Failed Process Score, in the overall cohort, the cyclical impact of the UK 
primary care QOF, in which maximal service effort is exerted to complete the key 
diabetes process measures in order to achieve end of year financial reimbursement, 
can easily be discerned. Both groups showed a significant improvement over the 
QOF time frame but with a significant better attainment in those multiply mailed, 
meaning that a discernable effect was demonstrated in the face of performance 
managed service activation.  In the whole cohort, almost 60% were already in a high 
attainment position and thus could not be further benefitted. When considering those 
with poorer baseline attainment (FPS>=2), at the end of 12 months they were 15% 
relatively more likely to be in the higher attainment category (FPS >=1).  Thus the 
impact of mailing singly (as initially published) and then multiply versus singly can be 
seen to have achieved its objective of having a significant impact over and above 
that of the current maximal driver of diabetes service activation, namely QOF, and to 
have separately benefited the intended target groups in lower attainment categories. 
 
The impact on HbA1c can be similarly considered. Our a-priori expectation was that 
if any differential impact were to have occurred, it would have been in those with 
poorer baseline glycaemic control but, in hind sight, the opposite outturn is perhaps 
both predictable and understandable. As is well recognised, the focus of clinicians 
and services will be on poorly controlled patients (5, 15), service inertia and delay is 
a crucial reason for poor attainment in such patients (16, 17) and the propensity to 
improve is almost certainly dependent on service intervention through drug titration 
and, in many patients, escalation to injectable therapies (18). A patient in this 
category is unlikely to have been able to influence their own outcome over and 
above the impact of service interventions. However, in the better baseline HbA1c 
attainment cohort (HbA1c ≤7.5%), the service would have been less focused on 
them as they were already at or below the UK HbA1c attainment target (19), there 
would have been no perception that drug therapies required modification, and 
patients would have been more likely to have been able to significantly modify their 
own already good attainment perhaps by diet and life style interventions or by 
improved concordance. The multiply mailed group essentially maintained their 
HbA1c whilst the comparators deteriorated relatively by 0.3 HbA1c%. This seems 
small, but roughly equates half of the size of effect of the addition of a second or 
third line oral hypoglycaemic agent in Type 2 diabetes (20) but in this case, a benefit 
deliverable to thousands of patients. It is the same if not better magnitude of effect 
as seen in highly structured education programmes such as DESMOND or 
DAFNE(21, 22). It is regrettable that we are not able to comment on the potential 
impact of single mailing, or otherwise multiple mailing, compared to not being mailed 
at all, but a logical assumption is that multiple mailing would have achieved some 
degree of greater benefit if it had been compared to no mailing at all. We have 
already addressed the question as to where a single mailing has benefit (to FPS) 
and now show multiple mailing has added benefit over single mailing (to FPS and 
HbA1c).  
 
Comparison with existing literature: 
The small size of any magnitude of effect can be further considered in the light of 
know evidence. In a recent metanalysis, non - pharmacological interventions were 
extensively reviewed (5) and they can be categorised into 3 categories of quality 
improvement strategies targeting health systems, healthcare providers and people 
with diabetes.   It was concluded in this review that health system wide interventions 
and patient focused strategies are more likely to influence outcomes in low to 
intermediate risk groups, while the high risk group gets most benefit from strategies 
focusing on interventions by healthcare professionals; pointing to the possible 
beneficial impact and increasing need for service activation in this high risk group 
(16, 17). In this context, all such non – pharmacological interventions have only 
shown modest improvements in hard; albeit surrogate, outcomes such as HbA1C of 
the average magnitude of 0.37 %, precisely in line with the magnitude of benefit that 
we currently demonstrate. 
 
Strengths and Limitations: 
 
The strength of the study is its large size, no selection bias and a cluster randomised 
design that made it possible to evidence this intervention in a highly complex care 
delivery structure of the NHS.   
 
The limitations of the study are acknowledged to be the relatively small magnitude of 
change observed, the relatively short time frame to first assessment of the multiply 
mailed vs. the single mailed group and the inability to assess hard longer term 
clinical outcomes within that time frame. It is possible that the reported observed 
benefit at 3 months (13) could have been by chance or random finding but 
persistence of improvement at the end of 12 months has confirmed the benefits of 
intervention. A significant disadvantage of the study is that there is not a control 
group that received no intervention of any sort, but we were obligated to fit in the with 
local NHS service cycles and to accept a perception of lack of equity in having a 
control group with no intervention at a time when we had already demonstrated a 
variety of benefits of the proposed intervention (13,14, 23, 24, 25). We were not 
aware of the language and literacy status of our studied population and the booklet 
was not translated into multiple other languages but considering that Wolverhampton 
is an urban area ranked 21st for deprivation in England (26) , with a 30% ethnic 
minority build, is ranked 16th in the UK for poor  attainment  of qualifications (27); 
although the data were tested for the impact of deprivation score which did  not have 
an impact on our findings, and probably adds to the strength of our findings.  The 
strength of the study also includes its minimal loss to follow up and cluster 
randomisation methodology used to provide robust evidence in this evidence 
deficient arena of diabetes care.  
 
 
In summary, in a large randomised controlled trial, we have demonstrated that the 
provision of structured diabetes-specific clinical information, through a specifically 
designed booklet, led to significant improvements in diabetes process outcomes. We 
also show impact on the long term measure of glucose control. We are not aware of 
any previously published randomised control trial in diabetes of a whole health 
economy intervention that is evidence to lead to patient activation. 
 
  
Implications for Research and Practice: 
We conclude that people with diabetes are manifestly able to understand their most 
important diabetes related information when it is presented to them in a simple but 
structured format and that this promotes their activation in discernible and 
measurable outcomes.  The booklet is easy to generate, and is seemingly low tech, 
with the proviso that the enabling background complexities of data integration and 
quality assurance are at a very high and well governed standard. Thus it should be 
easily reproducible in other health economies. It can be disseminated independently 
of health care professionals, and so is not reliant on service activation, nor dogged 
by service inertia, and it can be systematically distributed across a whole population.  
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How it Fits: 
1. Completion of structured diabetes care processes can be influenced by 
patient focused interventions. 
 
2. Provision of patient specific written information can drive care and improve 
access to health care and diabetes specific surrogate marker such as HbA1C. 
 
3. Improved engagement and better access can be taken as indirect measures 






The demographics and clinical parameters of those receiving multiple mailings of a 
structured information booklet (MM, 0, 3 and 6 months) compared to those mailed 
singly (SM, 3 months). Results are the means +- SD or otherwise percentages.  
 
Demographic data MM  
N = 8045 
SM 
N = 5911 
P value 
Age (years) 63.9 ± 14.5 63.4 ± 14.4 NS 
Sex (male) 54% 55% NS 
Ethnicity (White) 69% 70% NS 
Deprivation Score 35.2 ± 15.7 35.9 ± 16.6 P < 0.05 
Type 2 Diabetes 94% 94% NS 
Duration of Diabetes 10.4 ± 8.4 10.5 ± 8.7 NS 
Smoking (never smoked)  60% 60% NS 
    
Clinical Parameters    
BMI (kg/m2) 30.9 ± 6.3 31.1 ± 6.3 P <0.05  
BP (mm Hg) 135 ± 16 132 ± 16 P <0.001 
HbA1C DCCT (% glycated)  
HbA1c IFC (mmol/mol) 
7.8 ± 1.7 
61.5 ± 18.1 
7.8 ± 1.7 
61.6 ± 18.3 
NS 
NS 
Urine ACR (mg/mmol) 8.7 ± 34.6 8.9 ± 43.9 NS 
Creatinine (µmol/l) 88.3 ± 43.2 89.1 ± 46.4 NS 
Chol /HDL Chol Ratio 3.8 ± 1.4 3.8 ± 1.4 NS 
Cardiovascular status (primary risk) 71% 69% P <0.01 
10 year Framingham CHD risk (%) 18.0 ± 7.5 17.8 ± 7.4 NS 
Any Retinopathy  58% 57% NS 






A comparison of the Failed Process Score (FPS) between those multiply mailed 
(MM, 3 mailings) versus those singly mailed (SM) in the whole cohort or those with a 
baseline FPS <=1 or ≥2.  Results are the means ± SD and are analysed by the Mann 
Whitney U test. 
 
 MM SM P value 
FPS Whole cohort N = 8045 N= 5911  
Baseline 1.70 ± 1.78 1.71 ± 1.81 NS 
12 Months 1.65 ± 1.92 1.72 ± 1.95 P = 0.013 
    
FPS <=1 N = 4665 N = 3412  
 0.50 ± 0.50 0.40 ± .50 NS 
 1.23 ± 1.47 1.24 ±1.50 NS 
    
FPS ≥2 N = 3380 N = 2499  
Baseline 3.35 ± 1.58 3.38 ± 1.61 NS 






The mean (top panel)  and delta (bottom panel) HbA1c outcomes at the end of 12 
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